Leaf4Life

KizaVie. Transforming Hypoxia from an Unsolved Challenge into a Therapeutic Opportunity. Hypoxia, a leading cause of 30 million deaths annually, drives mortality across cancer, ARDS, trauma, and other conditions, yet no therapy directly corrects it. KizaVie addresses hypoxia, ARDS patients achieved 92% survival rates, compared to 40% with SOC.